Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 GBP
−40.22 M GBP
55.20 M GBP
181.41 M
About ALLERGY THERAPEUTICS ORD GBP0.001
Sector
CEO
Manuel Llobet
Headquarters
Worthing
Website
Founded
2004
ISIN
GB00B02LCQ05
FIGI
BBG000F797G5
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AGY is 5.52 GBX — it has decreased by −1.82% in the past 24 hours. Watch ALLERGY THERAPEUTICS ORD GBP0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ALLERGY THERAPEUTICS ORD GBP0.001 stocks are traded under the ticker AGY.
AGY stock has fallen by −3.57% compared to the previous week, the month change is a 17.90% rise, over the last year ALLERGY THERAPEUTICS ORD GBP0.001 has showed a 206.92% increase.
We've gathered analysts' opinions on ALLERGY THERAPEUTICS ORD GBP0.001 future price: according to them, AGY price has a max estimate of 13.00 GBX and a min estimate of 13.00 GBX. Watch AGY chart and read a more detailed ALLERGY THERAPEUTICS ORD GBP0.001 stock forecast: see what analysts think of ALLERGY THERAPEUTICS ORD GBP0.001 and suggest that you do with its stocks.
AGY stock is 17.45% volatile and has beta coefficient of 0.61. Track ALLERGY THERAPEUTICS ORD GBP0.001 stock price on the chart and check out the list of the most volatile stocks — is ALLERGY THERAPEUTICS ORD GBP0.001 there?
Today ALLERGY THERAPEUTICS ORD GBP0.001 has the market capitalization of 262.15 M, it has increased by 1.82% over the last week.
Yes, you can track ALLERGY THERAPEUTICS ORD GBP0.001 financials in yearly and quarterly reports right on TradingView.
ALLERGY THERAPEUTICS ORD GBP0.001 is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
AGY net income for the last half-year is −24.57 M GBP, while the previous report showed −15.65 M GBP of net income which accounts for −56.95% change. Track more ALLERGY THERAPEUTICS ORD GBP0.001 financial stats to get the full picture.
No, AGY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLERGY THERAPEUTICS ORD GBP0.001 EBITDA is −31.23 M GBP, and current EBITDA margin is −56.57%. See more stats in ALLERGY THERAPEUTICS ORD GBP0.001 financial statements.
Like other stocks, AGY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLERGY THERAPEUTICS ORD GBP0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLERGY THERAPEUTICS ORD GBP0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLERGY THERAPEUTICS ORD GBP0.001 stock shows the buy signal. See more of ALLERGY THERAPEUTICS ORD GBP0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.